Active ingredientRolapitantCat. No. P-R081-001CAS 552292-08-7Family · Pharmaceutical analytical standards
Rolapitant
An antagonist of the NK1 receptor, the target of substance P, approved in the United States in 2015 to prevent delayed chemotherapy-induced nausea and vomiting. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Its half-life is about a week: a single administration before chemotherapy also covers the delayed phase of nausea, which lasts up to about five days.
Go to the active ingredient →Active ingredientRolapitantCat. No. P-R081-001CAS 552292-08-7
Active ingredientRolapitant HClCat. No. P-R081-002CAS 858102-79-1
Isotopically labelledRolapitant-d4Cat. No. P-R081-003
NitrosamineN-Nitroso RolapitantCat. No. P-R081-004
ImpurityRolapitant (1R,2R,3R)-IsomerCat. No. P-R081-005CAS 1214741-26-0
ImpurityRolapitant (1R,2R,3S)-IsomerCat. No. P-R081-006CAS 1214741-25-9
ImpurityRolapitant (1R,2S,3R)-IsomerCat. No. P-R081-007CAS 552292-73-6
ImpurityRolapitant (1S,2R,3R)-IsomerCat. No. P-R081-008CAS 1214741-30-6
ImpurityRolapitant (1S,2R,3S)-IsomerCat. No. P-R081-009CAS 1214741-28-2
ImpurityRolapitant (1S,2S,3R)-IsomerCat. No. P-R081-010CAS 1214741-29-3
ImpurityRolapitant (1S,2S,3S)-IsomerCat. No. P-R081-011CAS 1214741-27-1
ImpurityRolapitant-M19Cat. No. P-R081-012CAS 2238886-63-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.